Clinical microbiome studies can generate large volumes of sequencing data. Their practical value, however, depends on decisions made across study scoping, sample handling, controls, sequencing, quality review and downstream analysis. This webinar examines how those decisions determine the path from microbiome data to robust biological interpretation.
Why attend
Hear practical perspectives from BaseClear and experts on the considerations that help clinical researchers, sponsors and R&D teams plan microbiome studies and use the resulting data more effectively.
You will explore how to:
- plan sample collection, controls and batch strategy with downstream interpretation in mind;
- choose a sequencing and analysis approach that fits the study question;
- move from taxonomic profiles towards functional and clinically relevant interpretation;
- frame the right technical and scientific questions before a study begins.
Who it is for
Clinical trial sponsors, CROs, clinical researchers, principal investigators, bioinformaticians, microbiome-focused biotech teams, probiotic and live biotherapeutic developers, nutrition and infant-health organisations, and R&D or innovation leaders working with clinical microbiome studies.
